OPEN B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

LEUKEMIA

NATURE PUBLISHING GROUP

1. Novo Nordisk Fonden [NNF12OC0002036] Funding Source: researchfish
2. Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen] Funding Source: researchfish
3. The Danish Cancer Society [R72-A4460, R72-A4571] Funding Source: researchfish